$3.35
-0.17-4.83%
Last update: Oct 30, 1:55 PM
Galectin Therapeutics Inc (GALT) Stock Price, Quote, News & History
GALTNASDAQ
Goldman Sachs (NYSE: GS) shares surged 6.9% after beating earnings estimates. Other big gainers include PHOE, SKHY, GALT, AXTI, FCEL, AAOI, CHRN, TSEM, YSS,...
You can purchase shares of Galectin Therapeutics (NASDAQ:GALT) through any online brokerage.
Other companies in Galectin Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Galectin Therapeutics has a consensus price target of $8.50.
The stock price for Galectin Therapeutics (NASDAQ: GALT) is $3.35 last updated October 30, 2026 at 1:55 PM EDT.
There are no upcoming dividends for Galectin Therapeutics.
Galectin Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Galectin Therapeutics.
Galectin Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin...
